Cost-Utility of First-Line Adalimumab and Tocilizumab Monotherapies in Rheumatoid Arthritis Based on Head-To-Head Data

Nov 1, 2013, 00:00
10.1016/j.jval.2013.08.1506
https://www.valueinhealthjournal.com/article/S1098-3015(13)03411-6/fulltext
Title : Cost-Utility of First-Line Adalimumab and Tocilizumab Monotherapies in Rheumatoid Arthritis Based on Head-To-Head Data
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(13)03411-6&doi=10.1016/j.jval.2013.08.1506
First page : A566
Section Title : Disease-Specific Studies
Open access? : No
Section Order : 1350
Categories :
Tags :
Regions :
ViH Article Tags :